Study: Treat-to-Target Success in Early RA Is Durable

(MedPage Today) -- Success with "treat-to-target" therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of the first clinical trials aimed at testing the strategy...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news